China Foods Holdings Ltd. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that China Foods Holdings Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $0 | May 24, 2019 |
| FY2018 | Sep 30, 2017 | $0 | May 24, 2019 |
| FY2017 | Sep 30, 2016 | $0 | Dec 27, 2017 |
| FY2016 | Sep 30, 2015 | $0 | Nov 30, 2016 |
| FY2015 | Sep 30, 2014 | $0 | Dec 16, 2015 |
| FY2014 | Sep 30, 2013 | $0 | Dec 3, 2014 |
| FY2013 | Sep 30, 2012 | $0 | Nov 12, 2013 |
| FY2012 | Sep 30, 2011 | $0 | Dec 19, 2012 |
| FY2011 | Sep 30, 2010 | $0 | Dec 23, 2011 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $327.9K | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | $233.3K | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | $158.5K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $354.1K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $361.1K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.01M | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $3.38M | Apr 13, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.0K | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | $53.9K | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | $64.1K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $111.1K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $239.4K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $416.6K | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $720.2K | Apr 13, 2021 |
| FY2018 | Sep 30, 2018 | $0 | May 24, 2019 |
| FY2018 | Sep 30, 2017 | $0 | May 24, 2019 |
| FY2017 | Sep 30, 2016 | $0 | Dec 27, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($398.7K) | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | ($455.6K) | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | ($403.7K) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($354.1K) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($455.4K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($469.5K) | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $82.8K | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | ($89.5K) | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | ($62.8K) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($54.9K) | May 24, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($398.9K) | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | ($455.6K) | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | ($404.6K) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($392.7K) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($456.4K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($470.8K) | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $88.5K | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | ($89.5K) | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | ($42.3K) | Dec 31, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($389.3K) | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | ($353.8K) | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | ($316.9K) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($171.6K) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($438.6K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $343.7K | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $706.0K | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | ($6.6K) | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | ($35.1K) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($30.1K) | May 24, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $23.5K | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | $746 | Apr 14, 2025 |
| FY2022 | Dec 31, 2021 | $27.4K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $75.1K | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $120.6K | Apr 13, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $212.9K | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | $435.0K | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | $365.2K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $679.2K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.57M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.53M | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $1.87M | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | $23.4K | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | $0 | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $18.5K | May 24, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49M | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | $1.29M | Apr 16, 2026 |
| FY2020 | Dec 31, 2020 | $697.3K | Apr 13, 2021 |
| FY2020 | Dec 31, 2019 | $468.3K | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | $130.8K | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | $18.1K | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $324.3K | May 24, 2019 |
| FY2017 | Sep 30, 2016 | $268.6K | Dec 27, 2017 |
| FY2016 | Sep 30, 2015 | $215.9K | Nov 30, 2016 |
| FY2015 | Sep 30, 2014 | $166.8K | Dec 16, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.28M) | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | ($850.8K) | Apr 16, 2026 |
| FY2025 | Dec 31, 2023 | ($390.8K) | Apr 16, 2026 |
| FY2024 | Dec 31, 2022 | $17.4K | Apr 14, 2025 |
| FY2023 | Dec 31, 2021 | $400.7K | Apr 16, 2024 |
| FY2022 | Dec 31, 2020 | $834.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $1.40M | Feb 7, 2023 |
| FY2019 | Sep 30, 2019 | ($107.4K) | Dec 31, 2019 |
| FY2020 | Dec 31, 2018 | $1.33M | Apr 13, 2021 |
| FY2019 | Sep 30, 2018 | ($18.1K) | Dec 31, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.53M) | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | ($2.13M) | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | ($1.68M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($1.27M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($918.2K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($462.8K) | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $159.4K | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | ($595.5K) | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | ($506.0K) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($443.3K) | May 24, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.9K | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | $39.2K | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | $174.9K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $381.7K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $609.4K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.01M | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | $634.5K | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | $23.4K | Dec 31, 2019 |
| FY2018 | Sep 30, 2018 | $0 | May 24, 2019 |
| FY2018 | Sep 30, 2017 | $15.1K | May 24, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Feb 7, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.25M | Apr 16, 2026 |
| FY2025 | Dec 31, 2024 | 20.25M | Apr 16, 2026 |
| FY2024 | Dec 31, 2023 | 20.25M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 20.25M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 20.25M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 20.25M | Feb 7, 2023 |
| FY2020 | Dec 31, 2019 | 15.00M | Apr 13, 2021 |
| FY2019 | Sep 30, 2019 | 5.25M | Dec 31, 2019 |
| FY2019 | Sep 30, 2018 | 5.25M | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | 5.25M | May 24, 2019 |